Chronic recurrent multifocal osteomyelitis in children and adults: current understanding and areas for development

Rheumatology (Oxford). 2018 Jan 1;57(1):41-48. doi: 10.1093/rheumatology/kex066.

Abstract

Since the first descriptions of chronic recurrent multifocal osteomyelitis in the 1970s, there have been numerous case reports in the literature; both unusual case reports and case series from all over the world. Our understanding of the pathogenesis has significantly changed, with it now being regarded as an autoinflammatory condition. Treatment options have also expanded, but little progress has been made in developing the evidence for treatments. Advancing gene studies have provided a mouse model, but the quest for a single gene to match the phenotype has been elusive. Early cohorts of patients have grown up into adults, allowing prospective data to inform the expected outcomes.

Keywords: autoinflammation; chronic non-bacterial osteitis; chronic recurrent multifocal osteomyelitis.

Publication types

  • Review

MeSH terms

  • Adult
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Autoimmune Diseases / diagnostic imaging
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / immunology*
  • Biological Products / therapeutic use
  • Bone Density Conservation Agents / therapeutic use
  • Child
  • Diphosphonates / therapeutic use
  • Disease Models, Animal
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunity, Innate / immunology*
  • Inflammation / diagnostic imaging
  • Inflammation / drug therapy
  • Inflammation / genetics
  • Inflammation / immunology*
  • Magnetic Resonance Imaging
  • Mice
  • Osteomyelitis / diagnostic imaging
  • Osteomyelitis / drug therapy
  • Osteomyelitis / genetics
  • Osteomyelitis / immunology*
  • Whole Body Imaging

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • Biological Products
  • Bone Density Conservation Agents
  • Diphosphonates
  • Glucocorticoids

Supplementary concepts

  • Chronic recurrent multifocal osteomyelitis